New Heart Valve for Severe Aortic Leak
Part of Heart & circulation clinical trials.
This study is testing a new, less invasive heart valve system (TaurusTrio) for people with severe aortic regurgitation (a leaky aortic valve) who cannot have open-heart surgery. It aims to see if the valve is safe and works well to improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have severe aortic regurgitation (a leaky aortic valve) causing symptoms like shortness of breath or chest pain.
- Your heart team has decided that open-heart surgery is too risky for you, but you are still a candidate for a less invasive valve replacement called TAVR.
- Your aortic valve anatomy (size and shape) must be suitable for the study's special heart valve system, as determined by imaging tests.
- You must not have had a previous valve replacement or certain other heart or medical conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This trial tests whether a 3D computer simulation can help guide a less invasive procedure (TAVR) to replace a leaky aortic valve. It may be an option for people with severe aortic regurgitation who are at least 65 years old.
This study tests a new valve replacement for people with severe aortic regurgitation (leaky heart valve) who are not good candidates for open surgery. The valve is put in through a small tube in the leg, which may be less risky for high-risk patients.
This trial compares a new less-invasive valve replacement (Trilogy TAVR) with standard open-heart surgery for people with significant aortic regurgitation. It aims to see which treatment works better for patients who are eligible for both procedures.
This study tests a less invasive procedure to replace a leaky aortic valve in people who can't have open-heart surgery. The goal is to help your heart pump better and reduce symptoms.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
Hear when a new Aortic Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.